Showing results (141-150 of 185) with videos related to

Sort By:
Pageof 19
Stroke|October 27, 2022
Redefining Disability: Patient-Reported Outcome Measures After Minor Stroke and Transient Ischemic AttackMarta Olive-Gadea, David Cano, Marc Rodrigo-Gisbert, et al.
Journal of the American College of Cardiology|April 20, 2019
Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial EnergeticsCarlos G Santos-Gallego, Juan Antonio Requena-Ibanez, Rodolfo San Antonio, et al.
Antibiotics (Basel, Switzerland)|January 21, 2022
Is Antibiotic Prophylaxis Necessary before Dental Implant Procedures in Patients with Orthopaedic Prostheses? A Systematic ReviewAngel-Orión Salgado-Peralvo, Juan-Francisco Peña-Cardelles, Naresh Kewalramani, et al.
International Journal of Environmental Research and Public Health|February 11, 2023
State of the Oral Implantology Practice in Spain during the COVID-19 Pandemic: A Cross-Sectional SurveyÁngel-Orión Salgado-Peralvo, Daniel Fernández-Cerero, Alvaro Garcia-Sanchez, et al.
Surgical Endoscopy|May 30, 2019
The fusion fascia of Fredet: an important embryological landmark for complete mesocolic excision and D3-lymphadenectomy in right colon cancerAlvaro Garcia-Granero, Gianluca Pellino, Matteo Frasson, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|July 3, 2025
Importance of connectivity for carnivore richness and occupancy in fragmented biodiversity hotspotsCindy M Hurtado, Gonçalo Curveira-Santos, Alvaro Garcia-Olaechea, et al.
Stroke|January 11, 2021
Defining a Target Population to Effectively Test a Neuroprotective DrugMarta Olivé-Gadea, Manuel Requena, Daniel Campos, et al.
Drug Testing and Analysis|November 22, 2023
Design of smart nanoparticles for the electrochemical detection of 3,4-methylenedioxymethamphetamine to allow in field screening by law enforcement officersFlorina Maria Truta, Alvaro Garcia Cruz, Ana-Maria Dragan, et al.
Cardiovascular Drugs and Therapy|January 25, 2019
Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity?Carlos G Santos-Gallego, Alvaro Garcia-Ropero, Donna Mancini, et al.
Pageof 19